MedHelp trading update for the second quarter 2025
25 juli, 07:50
As a result of Roxellen BidCo's[1] announcement of a recommended public cash offer for all shares in MedHelp Care Aktiebolag (publ) ("MedHelp" or the "Company") earlier today, MedHelp announces certain preliminary information regarding the second quarter of 2025.
In the second quarter of 2025, MedHelp continues to show strong earnings growth. Net sales for the second quarter amounted to SEK 20.8 million (SEK 20.1 million), an increase of 3.5%. CARR amounted to SEK 83.1 million, which is slightly lower than last year. A continued high gross margin of 88.8% (88.0%) and lower Other operating expenses of SEK -16.2 million (SEK -17.6 million) result in EBITDA of SEK 4.0 million (SEK 2.3 million). Cash flow from operating activities during the second quarter amounted to SEK 5.2 million (SEK 3.3 million).
During the period January to June 2025, Net sales amounted to SEK 43.0 million (SEK 41.3 million), an increase of 4.2%, and Total revenues amounted to SEK 47.1 million (SEK 45.9 million). EBITDA amounted to SEK 8.8 million (SEK 4.3 million), corresponding to a doubling compared to the corresponding period last year. Cash flow from operating activities for the period January to June amounted to SEK 10.3 million (SEK 4.0 million) and profit for the period amounted to SEK 3.3 million (SEK -0.9 million).
Financial summary
Group | Q2 2025 | Q2 2024 | Jan–Jun 2025 | Jan–Jun 2024 | Jan–Dec 2024 |
Net Sales | 20 826 | 20 116 | 43 032 | 41 305 | 82 310 |
Net Sales Increase % | 3,5 | -2,0 | 4,2 | -1,8 | -2,1 |
Gross Profit | 20 157 | 19 978 | 41 162 | 39 510 | 79 727 |
Gross Profit Margin % | 88,8% | 88,0% | 89,7% | 86,1% | 87,5% |
EBITDA | 3 952 | 2 338 | 8 775 | 4 328 | 13 905 |
EBITDA Margin % | 18,98 | 11,62 | 20,39 | 10,48 | 16,89 |
Net Income | 1 533 | -624 | 3 270 | -939 | 2 081 |
Net Income per Share | 0,05 | -0,02 | 0,11 | -0,03 | 0,07 |
Cash Flow from Operating Activities | 5 235 | 3 280 | 10 262 | 4 041 | 9 684 |
CARR | 83 115 | 83 682 | 83 115 | 83 682 | 86 352 |
All figures are preliminary and have not been reviewed by the Company's auditors. The complete interim report for the second quarter 2025 will be published on 15 August 2025.
For further information, please contact:
Tobias Ekros, CEO
tobias.ekros@medhelpcare.com
Phone: +46 8 528 528 00
About Medhelp Care
MedHelp Care offers a Health Platform that is used by more than 500 companies and organizations in the systematic health work and management of sick leave and rehabilitation. Using AI and health data, MedHelp Care identifies early signs of ill health and helps managers and HR to work proactively with preventive measures. MedHelp Care is listed on Nasdaq First North.
For more information, see MedHelp Care's website www.medhelp.se
The company's Certified Adviser is DNB Carnegie.
[1] Under name change from Goldcup 37953 AB.
This information is information that MedHelp Care AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-07-25 07:50 CEST.
Attachments
Ämnen i artikeln
MedHelp trading update for the second quarter 2025
25 juli, 07:50
As a result of Roxellen BidCo's[1] announcement of a recommended public cash offer for all shares in MedHelp Care Aktiebolag (publ) ("MedHelp" or the "Company") earlier today, MedHelp announces certain preliminary information regarding the second quarter of 2025.
In the second quarter of 2025, MedHelp continues to show strong earnings growth. Net sales for the second quarter amounted to SEK 20.8 million (SEK 20.1 million), an increase of 3.5%. CARR amounted to SEK 83.1 million, which is slightly lower than last year. A continued high gross margin of 88.8% (88.0%) and lower Other operating expenses of SEK -16.2 million (SEK -17.6 million) result in EBITDA of SEK 4.0 million (SEK 2.3 million). Cash flow from operating activities during the second quarter amounted to SEK 5.2 million (SEK 3.3 million).
During the period January to June 2025, Net sales amounted to SEK 43.0 million (SEK 41.3 million), an increase of 4.2%, and Total revenues amounted to SEK 47.1 million (SEK 45.9 million). EBITDA amounted to SEK 8.8 million (SEK 4.3 million), corresponding to a doubling compared to the corresponding period last year. Cash flow from operating activities for the period January to June amounted to SEK 10.3 million (SEK 4.0 million) and profit for the period amounted to SEK 3.3 million (SEK -0.9 million).
Financial summary
Group | Q2 2025 | Q2 2024 | Jan–Jun 2025 | Jan–Jun 2024 | Jan–Dec 2024 |
Net Sales | 20 826 | 20 116 | 43 032 | 41 305 | 82 310 |
Net Sales Increase % | 3,5 | -2,0 | 4,2 | -1,8 | -2,1 |
Gross Profit | 20 157 | 19 978 | 41 162 | 39 510 | 79 727 |
Gross Profit Margin % | 88,8% | 88,0% | 89,7% | 86,1% | 87,5% |
EBITDA | 3 952 | 2 338 | 8 775 | 4 328 | 13 905 |
EBITDA Margin % | 18,98 | 11,62 | 20,39 | 10,48 | 16,89 |
Net Income | 1 533 | -624 | 3 270 | -939 | 2 081 |
Net Income per Share | 0,05 | -0,02 | 0,11 | -0,03 | 0,07 |
Cash Flow from Operating Activities | 5 235 | 3 280 | 10 262 | 4 041 | 9 684 |
CARR | 83 115 | 83 682 | 83 115 | 83 682 | 86 352 |
All figures are preliminary and have not been reviewed by the Company's auditors. The complete interim report for the second quarter 2025 will be published on 15 August 2025.
For further information, please contact:
Tobias Ekros, CEO
tobias.ekros@medhelpcare.com
Phone: +46 8 528 528 00
About Medhelp Care
MedHelp Care offers a Health Platform that is used by more than 500 companies and organizations in the systematic health work and management of sick leave and rehabilitation. Using AI and health data, MedHelp Care identifies early signs of ill health and helps managers and HR to work proactively with preventive measures. MedHelp Care is listed on Nasdaq First North.
For more information, see MedHelp Care's website www.medhelp.se
The company's Certified Adviser is DNB Carnegie.
[1] Under name change from Goldcup 37953 AB.
This information is information that MedHelp Care AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-07-25 07:50 CEST.
Attachments
Ämnen i artikeln
Handelskrig
Apple
Analys
Handelskrig
Apple
Analys
Marknadsöversikt
1 DAG %
Senast
1 mån
Privatekonomi med Placeras expert
Affärsvärlden
